BacterOMIC

Warsaw, Poland Founded: 2017 • Age: 9 yrs
Developer of a system for antibiotic susceptibility testing
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 3 Brand Intelligence

About BacterOMIC

BacterOMIC is a company based in Warsaw (Poland) founded in 2017. BacterOMIC offers products and services including BACTEROMIC System, Universal Panel, and Custom AST Panel. BacterOMIC operates in a competitive market with competitors including Rapid Micro Biosystems and Rapiddx Technologies, among others.

  • Headquarter Warsaw, Poland
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Bacteromic Spółka Z Ograniczoną Odpowiedzialnością
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    -$369.7 K (USD)
    15
    as on Dec 31, 2020
  • EBITDA
    $3.14 K (USD)
    -42
    as on Dec 31, 2020
  • Latest Funding Round
    $2.13 M (USD), Grant

    Aug 01, 2019

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BacterOMIC

BacterOMIC offers a comprehensive portfolio of products and services, including BACTEROMIC System, Universal Panel, and Custom AST Panel.

Product name locked
Category locked
Primary

Evaluates antibiotic effectiveness against bacterial infections.

Product name locked
Category locked
Locked

Assesses susceptibility directly from positive blood cultures.

Product name locked
Category locked
Locked

Provides tailored testing for animal pathogen resistance.

People of BacterOMIC

Headcount 10-50
Employee Profiles 4
Employee Profiles
People
Bernd Eberhardt
CEO
People
Szymon Ruta
Chief Financial Officer
People
Anna S.
Manager Ds. Finansowych
People
Łukasz Richter
Product Manager

Unlock access to complete

Funding Insights of BacterOMIC

Investors in BacterOMIC

BacterOMIC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for BacterOMIC

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BacterOMIC

Investments
Premium access

Investment portfolio details for BacterOMIC

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BacterOMIC

Premium access

Detailed financials for BacterOMIC

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bacteromic Comparisons

BacterOMIC Primary company
Description
Developer of a system for antibiotic susceptibility testing
Location
Warsaw, Poland
Founded Year
2017
Annual Revenue
Not available
Net Profit
-$369.7 K (USD)
EBITDA
$3.14 K (USD)
Employees
Not available
Premium access

Peer comparison for BacterOMIC

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BacterOMIC

BacterOMIC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Micro Biosystems and Rapiddx Technologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biosystems for microbial contamination detection are developed and supplied.
Locked Locked Locked
Antimicrobial susceptibility platform is developed via microfluidics and sensor technology.
Premium access

Detailed competitors of BacterOMIC

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bacteromic

Premium access

Complete news archive for BacterOMIC

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BacterOMIC

BacterOMIC was founded in 2017 and raised its 1st funding round 2 years after it was founded.

BacterOMIC is headquartered in Warsaw, Poland.

Developer of a system for antibiotic susceptibility testing. The system has a disposable panel that contains various antibiotics and a checkerboard combination of antibiotics. It is developed by combining microfluidics, detection, data analysis, and automation which helps in determining the treatment of MDR pathogens.

BacterOMIC's top competitors include Rapid Micro Biosystems and Rapiddx Technologies.

BacterOMIC offers BACTEROMIC System, Universal Panel, and Custom AST Panel.

BacterOMIC has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available